Nemes Rush Group’s Eli Lilly LLY Stock Holding History

Nemes Rush Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14M	Sell	15,197 -164	-1%	-$166K	1.33%	27
2025 Q4	$16.5M	Buy	15,361 +94	+0.6%	+$89.9K	1.55%	20
2025 Q3	$11.6M	Buy	15,267 +369	+2%	+$275K	1.15%	27
2025 Q2	$11.6M	Buy	14,898 +553	+4%	+$430K	1.26%	26
2025 Q1	$11.8M	Buy	14,345 +204	+1%	+$170K	1.5%	22
2024 Q4	$10.9M	Buy	14,141 +835	+6%	+$691K	1.35%	26
2024 Q3	$10.4M	Sell	13,306 -392	-3%	-$352K	1.5%	23
2024 Q2	$12.4M	Buy	13,698 +326	+2%	+$261K	1.7%	18
2024 Q1	$10.4M	Buy	13,372 +10,433	+355%	+$7.42M	1.49%	23
2023 Q4	$1.71M	Sell	2,939 -132	-4%	-$77K	0.28%	67
2023 Q3	$1.65M	Sell	3,071 -36	-1%	-$18.6K	0.3%	68
2023 Q2	$1.46M	Buy	+3,107	New	+$1.3M	0.26%	74

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nemes Rush Group's LLY Position: Q1 2026 in Review

Nemes Rush Group reduced its Eli Lilly (LLY) stake by 1.1% in Q1 2026, selling an estimated $166K and leaving 15,197 shares worth $14M. The position accounts for 1.33% of the portfolio, ranked #27.

Nemes Rush Group first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $16.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Nemes Rush Group held 15,197 shares of Eli Lilly worth $14M as of Q1 2026.
Nemes Rush Group sold 164 Eli Lilly shares in Q1 2026, an estimated $166K.
Eli Lilly made up 1.33% of Nemes Rush Group's portfolio in Q1 2026, its #27 holding.
Nemes Rush Group first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Nemes Rush Group's Eli Lilly position peaked at $16.5M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.